Given the recent influx of evidence suggesting a connection between the popular diabetes and weight loss drug, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), and various ocular adverse events, a new study aimed to investigate this potential association on a global scale
Their half-lives are around 1 week, allowing for weekly dosing
On licensing: REMEVi is licensed to provide care across all 50 states plus the District of Columbia full nationwide coverage
Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans
Hims advertises GLP-1 plans from a similar monthly price, but may charge additional fees for labs or consultations
Some common ones include nausea, vomiting, diarrhea, and constipation